Abstract
Objective:
We examined data from a contemporary cohort of extreme prematurity (EP) infants admitted to an all-referral Children’s Hospital neonatal intensive care unit (NICU) to determine whether prophylactic indomethacin (PI) may continue to benefit these patients.
Study Design:
An observational study utilizing the small baby ICU data registry that was queried for all EP infants admitted between 2005 and 2014 with documentation of PI use (671 total EP infants; 141 (21%) did not receive PI (control); 530 (79%) received PI (PI). This cohort of EP infants was born at outside hospitals and transferred to our level IV NICU with a mean age on admission of 13 days, well after the PI would have been administered.
Results:
No difference existed between the control and PI groups in gestational age, birth weight, severity of illness, other in-hospital outcomes or developmental delay. PI infants had a significantly lower mortality rate (P=0.0004), lower relative risk (RR) for mortality 0.52 (95% confidence interval (CI) 0.37 to 0.73, P=0.0001) and lower RR of developing the combined outcome of death or bronchopulmonary dysplasia (RR 0.91, 95% CI 0.85 to 0.98, P=0.012) when compared with the control group. Notably, there was no significant effect of PI on incidence of severe intraventricular hemorrhage or patent ductus arteriosus ligation.
Conclusion:
PI administration was associated with improved survival in EP infants referred to a level IV Children’s Hospital NICU.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Patel RM, Kandefer S, Walsh MC . Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med 2015; 372: 331–340.
Tyson JE, Parikh NA, Langer J, Green C, Higgins RD . Intensive care for extreme prematurity – moving beyond gestational age. N Engl J Med 2008; 358: 1672–1681.
Costeloe KL, Hennessy EM, Haider S, Stacey F, Marlow N, Draper ES . Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ 2012; 345: e7976.
Vento M, Cheung PY, Aguary M . The first golden minutes of the extremely-low-gestational-age neonate: a gentle approach. Neonatology 2009; 95 (4): 286–298.
Arzuaga BH, Meadow W . National variability in neonatal resuscitation practices at the limit of viability. Am J Perinatol 2014; 31 (6): 521–528.
Lorenz JM . The outcome of extreme prematurity. Semin Perinatol 2001; 25 (5): 348–359.
Volpe JJ . Impaired neurodevelopmental outcome after mild germinal matrix-intraventricular hemorrhage. Pediatrics 2015; 136 (6): 1185–1187.
Clyman RI, Couto J, Murphy GM . Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol 2012; 36 (2): 123–129.
Schneider DJ, Moore JW . Patent ductus arteriosus. Circulation 2006; 114 (17): 1873–1882.
Patel RM, Kandefer S, Walsh MC, Bell EF, Carlo WA, Laptook AR et al. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med 2015; 372: 331–340.
Horbar JD, Carpenter JH, Badger GJ, Kenny MJ, Soll RF, Morrow KA et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 2012; 129: 1019–1026.
Ment LR, Ehrenkranz RA, Duncan CC, Scott DT, Taylor KJW, Katz KH et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994; 93 (4): 543–550.
Ment LR, Oh W, Ehrenkranz RA, Phillip AGS, Vohr B, Allan W et al. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr 1994; 124 (6): 951–955.
Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 1966–1972.
Narayanan M, Cooper B, Weiss H, Clyman RI . Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. Pediatrics 2000; 136 (3): 330–337.
Moorehead PA, Martin EM, Shepherd EG, Parikh NA, Reagan PB, Gardner W et al. Factors associated with survival of <27 week infants in an all-referral neonatal intensive care unit. J Neonatal Perinatal Med 2012; 5: 105–111.
Nankervis CA, Martin EM, Crane ML, Samson KS, Welty SE, Nelin LD . Implementation of a multidisciplinary guideline-driven approach to the care of the extremely premature infant improved hospital outcomes. Acta Paediatr 2010; 99: 188–193.
Bartman T, Bapat R, Martin EM, Shepherd EG, Nelin LD, Reber KM . Apgar Score at 5 minutes is associated with mortality in extremely preterm infants even after transfer to an all referral NICU. Am J Perinatol 2015; 32: 1268–1272.
Fowlie PW, Davis PG, McGuire W . Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2010; 7: CD000174.
Fowlie PW, Davis PG Prophylactic indomethacin for preterm infants: a systematic review and meta-analysisArch Dis Child Fetal Neonatal Ed 2003; 88: F464–F466.
Couser RJ, Hoekstra RE, Berrara TB . Neurodevelopmental follow-up at 36 months’ corrected age of preterm infants treated with prophylactic indomethacin. Arch Pediatr Adolesc Med 2000; 154 (6): 598–602.
Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007; 357: 1893–1902.
Darlow BA, Graham PJ . Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev 2007; 17 (4): CD000501.
Doyle LW, Ehrenkranz RA, Halliday HL . Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology 2010; 98 (3): 217–224.
Lodha A, Seshia M, McMillan DD, Barrington K, Yang J, Lee SK et al. Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr 2015; 169 (1): 33–38.
Taha D, Kirkby S, Nawab U . Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants. J Matern Fetal Neonatal Med 2014; 27 (16): 1698–1702.
Clyman RI, Saha S, Jobe A, Oh W . Indomethacin prophylaxis for preterm infants: the impact of two multicentered randomized controlled trials on clinical practice. J Pediatr 2007; 150 (1): 46–50.
Guillén U, DeMauro S, Ma L, Zupancic J, Roberts R, Schmidt B et al. Relationship between attrition and neurodevelopmental impairment rates in extremely preterm infants at 18 to 24 months: a systematic review. Arch Pediatr Adolesc Med 2012; 166 (2): 178–184.
Horbar JD, Edwards EM, Greenberg LT, Morrow KA, Soll RF, Buus-Frank ME et al. Variation in performance of neonatal intensive care units in the United States. JAMA Pediatr 2017; 171 (3): e164396.
Rozé JC, Cambonie G, Marchand-Martin L, Gournay V, Durrmeyer X, Durox M et al. Association between early screening for patent ductus arteriosus and in-hospital mortality among extremely preterm infants. JAMA 2015; 313 (24): 2441–2448.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Nelin, T., Pena, E., Giacomazzi, T. et al. Outcomes following indomethacin prophylaxis in extremely preterm infants in an all-referral NICU. J Perinatol 37, 932–937 (2017). https://doi.org/10.1038/jp.2017.71
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2017.71
This article is cited by
-
Effects of prophylactic indomethacin on morbidity and mortality in infants <25 weeks’ gestation: a protocol driven intention to treat analysis
Journal of Perinatology (2022)
-
Model for severe intracranial hemorrhage and role of early indomethacin in extreme preterm infants
Pediatric Research (2022)
-
Development of a small baby unit to improve outcomes for the extremely premature infant
Journal of Perinatology (2022)
-
Effects of prophylactic indomethacin on intraventricular hemorrhage and adverse outcomes in neonatal intensive care unit
Journal of Perinatology (2022)
-
Prophylactic Indomethacin in extremely preterm infants: association with death or BPD and observed early serum creatinine levels
Journal of Perinatology (2021)